BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36902627)

  • 1. Pancreatic Neuroendocrine Neoplasms Larger than 4 cm: A Retrospective Observational Study of Surgery, Histology, and Outcome.
    Milanetto AC; Gais Zürcher AL; David A; Fassan M; Pasquali C
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
    Kurita Y; Hara K; Kuwahara T; Mizuno N; Okuno N; Haba S; Okuno M; Natsume S; Senda Y; Kubota K; Nakajima A; Niwa Y; Shimizu Y
    J Gastroenterol; 2020 May; 55(5):543-552. PubMed ID: 31858231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.
    Sadula A; Li G; Xiu D; Ye C; Ren S; Guo X; Yuan C
    Comput Math Methods Med; 2022; 2022():3689895. PubMed ID: 35720036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic pancreatic neuroendocrine neoplasms: A retrospective clinicopathological and outcome analysis from a Latvian study group.
    Ptasnuka M; Truskovs A; Ozolins A; Narbuts Z; Sperga M; Plaudis H
    Front Surg; 2023; 10():1131333. PubMed ID: 37021091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas.
    Capretti G; Nappo G; Smiroldo V; Cereda M; Branciforte B; Spaggiari P; Carrara S; Preatoni P; Gavazzi F; Ridolfi C; Donisi G; Lania A; Zerbi A
    Gastroenterol Res Pract; 2019; 2019():6856329. PubMed ID: 31182959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters.
    van Beek DJ; Nell S; Verkooijen HM; Borel Rinkes IHM; Valk GD; ; Vriens MR; ;
    Surgery; 2021 Apr; 169(4):963-973. PubMed ID: 33220975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on surgical treatment of pancreatic neuroendocrine neoplasms.
    D'Haese JG; Tosolini C; Ceyhan GO; Kong B; Esposito I; Michalski CW; Kleeff J
    World J Gastroenterol; 2014 Oct; 20(38):13893-8. PubMed ID: 25320524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study.
    Paik WH; Lee HS; Lee KJ; Jang SI; Lee WJ; Hwang JH; Cho CM; Park CH; Han J; Woo SM; Jeong S; Chon HK; Kim TN; Lee JK; Han JH; Yoon JH; Kim YT; Cho JH
    Pancreatology; 2021 Jan; 21(1):208-214. PubMed ID: 33281058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for resection and perioperative outcomes of surgery for pancreatic neuroendocrine neoplasms in Germany: an analysis of the prospective DGAV StuDoQ|Pancreas registry.
    Mintziras I; Keck T; Werner J; Fichtner-Feigl S; Wittel U; Senninger N; Vowinkel T; Köninger J; Anthuber M; Geißler B; Bartsch DK;
    Surg Today; 2019 Dec; 49(12):1013-1021. PubMed ID: 31240463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and Long-Term Outcomes of Laparoscopic Organ-Sparing Resection for Pancreatic Neuroendocrine Neoplasms.
    Zhang RC; Ma J; Mou YP; Zhou YC; Jin WW; Lu C
    World J Surg; 2020 Nov; 44(11):3795-3800. PubMed ID: 32700111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study.
    Zerbi A; Capitanio V; Boninsegna L; Delle Fave G; Pasquali C; Rindi G; Campana D; Falconi M;
    HPB (Oxford); 2013 Dec; 15(12):935-43. PubMed ID: 23472667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
    Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
    Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.
    Lopez CL; Waldmann J; Fendrich V; Langer P; Kann PH; Bartsch DK
    Langenbecks Arch Surg; 2011 Dec; 396(8):1187-96. PubMed ID: 21805182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
    Martin-Perez E; Capdevila J; Castellano D; Jimenez-Fonseca P; Salazar R; Beguiristain-Gomez A; Alonso-Orduña V; Martinez Del Prado P; Villabona-Artero C; Diaz-Perez JA; Monleon A; Marazuela M; Pachon V; Sastre-Valera J; Sevilla I; Castaño A; Garcia-Carbonero R
    Neuroendocrinology; 2013; 98(2):156-68. PubMed ID: 23988576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival.
    Massironi S; Rossi RE; Zilli A; Casazza G; Ciafardini C; Conte D
    Oncotarget; 2016 Apr; 7(14):18978-83. PubMed ID: 26959887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Neuroendocrine Neoplasms and Gastrointestinal Stromal Tumors: A Single-Institution Experience of a Rare Association and Review of the Literature.
    Milanetto AC; Pacciani S; Fassan M; Pasquali C
    Pancreas; 2020 Aug; 49(7):918-923. PubMed ID: 32658075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
    Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
    Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective.
    Muscogiuri G; Altieri B; Albertelli M; Dotto A; Modica R; Barrea L; Fanciulli G; Feola T; Baldelli R; Ruggeri RM; Gallo M; Guarnotta V; Malandrino P; Messina E; Venneri MA; Giannetta E; Ferone D; Colao A; Faggiano A;
    Endocrine; 2020 Aug; 69(2):441-450. PubMed ID: 32468269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.
    Vagefi PA; Razo O; Deshpande V; McGrath DJ; Lauwers GY; Thayer SP; Warshaw AL; Fernández-Del Castillo C
    Arch Surg; 2007 Apr; 142(4):347-54. PubMed ID: 17438169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of Current ENETS Guidelines for Surgery of Small (≤2 cm) Pancreatic Neuroendocrine Neoplasms in the German Surgical Community: An Analysis of the Prospective DGAV StuDoQ|Pancreas Registry.
    Mintziras I; Keck T; Werner J; Fichtner-Feigl S; Wittel U; Senninger N; Vowinkel T; Köninger J; Anthuber M; Geißler B; Bartsch DK;
    World J Surg; 2019 Jan; 43(1):175-182. PubMed ID: 30097704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.